Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience. - Archive ouverte HAL Access content directly
Journal Articles BMC Cancer Year : 2013

Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience.

Alice Levard
  • Function : Author
  • PersonId : 940186
Olfa Derbel
  • Function : Author
  • PersonId : 937382
Pierre Méeus
  • Function : Author
  • PersonId : 940187
Dominique Ranchère
  • Function : Author
  • PersonId : 940188
Isabelle Ray-Coquard
  • Function : Author
  • PersonId : 926866
Jean-Yves Blay
  • Function : Author
  • PersonId : 935658

Abstract

BACKGROUND: Solitary Fibrous Tumor is a rare type of soft tissue tumor of intermediate malignant potential which may recur or metastasize in 15-20% of cases. Data on the management of patients with advanced SFT is scarce: chemotherapy has been described as ineffective, while recent data suggests that anti-angiogenic therapies may be more efficient. METHODS: We conducted a retrospective study on patients treated for advanced SFT at a single institution: from January 1994 to December 2011, 30 patients were treated in the Centre Léon Bérard for an advanced SFT. RESULTS: Twenty-three patients received cytotoxic chemotherapy as first-line therapy. Best responses were 2 (9%) partial responses, 13 (57%) stable diseases (SD) and 8 (35%) progressive diseases (PD). Median Progression Free Survival (PFS) was 5.2 (95% CI: 3.2-7.1) months and 9 patients were free of progression at 6 months. Ten patients received an anti-angiogenic treatment (sunitinib or pazopanib) as a 2nd, 3rd or 4th line. Best responses were 5 SD and 5 PD; median PFS was 5.1 months (95% CI 0.7-9.6). Four patients (36%) were progression-free for more than 6 months. Two patients receiving pazopanib were without progression at 6 and 8 months and two patients receiving sunitinib were free of progression at 30 months. CONCLUSION: Response rate with standard chemotherapy was low and PFS appear similar between cytotoxic chemotherapy and anti-angiogenic agents.
Fichier principal
Vignette du fichier
1471-2407-13-109.pdf (182.08 Ko) Télécharger le fichier
1471-2407-13-109.xml (64.77 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Format : Other
Loading...

Dates and versions

inserm-00811931 , version 1 (11-04-2013)

Identifiers

Cite

Alice Levard, Olfa Derbel, Pierre Méeus, Dominique Ranchère, Isabelle Ray-Coquard, et al.. Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience.. BMC Cancer, 2013, 13 (1), pp.109. ⟨10.1186/1471-2407-13-109⟩. ⟨inserm-00811931⟩

Collections

INSERM
90 View
160 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More